- Conditions
- Hypercholesterolemia
- Interventions
- Lapaquistat acetate and stable statin therapy, Stable statin therapy
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 649 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 13
- States / cities
- Santa Ana, California • Chicago, Illinois • Iowa City, Iowa + 10 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–12
of 12
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Hypercholesterolemia
- Interventions
- Lapaquistat acetate, Placebo
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 224 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007
- U.S. locations
- 22
- States / cities
- Long Beach, California • Sacramento, California • San Diego, California + 19 more
- Conditions
- Type 2 Diabetes
- Interventions
- Lapaquistat acetate and lipid-lowering therapy, Lipid-lowering therapy
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 18
- States / cities
- Tucson, Arizona • Artesia, California • Jacksonville, Florida + 15 more
- Conditions
- Hyperlipidemias
- Interventions
- Lapaquistat acetate and fenofibrate, Fenofibrate
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 213 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 32
- States / cities
- Huntsville, Alabama • Sierra Vista, Arizona • Beverly Hills, California + 29 more
- Conditions
- Hypercholesterolemia
- Interventions
- Lapaquistat acetate and current lipid-lowering treatment, Current lipid-lowering treatment
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 8 Years and older
- Enrollment
- 44 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 2
- States / cities
- Cincinnati, Ohio • Columbus, Ohio
- Conditions
- Toxicity
- Interventions
- Pharmacogenomic whole blood sampling
- Other
- Lead sponsor
- Takeda
- Industry
- Eligibility
- Not listed
- Enrollment
- 66 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 4
- States / cities
- Jacksonville, Florida • Jupiter, Florida • Idaho Falls, Idaho + 1 more
- Conditions
- Dyslipidemia
- Interventions
- Lapaquistat Acetate, Placebo
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 361 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 47
- States / cities
- Northport, Alabama • Mesa, Arizona • Chula Vista, California + 44 more
- Conditions
- Hypercholesterolemia
- Interventions
- Lapaquistat acetate and atorvastatin, Atorvastatin
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 448 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 78
- States / cities
- Birmingham, Alabama • Northport, Alabama • Sierra Vista, Arizona + 75 more
- Conditions
- Hypercholesterolemia
- Interventions
- Lapaquistat acetate and simvastatin, Simvastatin
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,362 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 50
- States / cities
- Huntsville, Alabama • Chandler, Arizona • Scottsdale, Arizona + 47 more
- Conditions
- Dyslipidemia
- Interventions
- Lapaquistat acetate, Lapaquistat acetate and atorvastatin, Atorvastatin
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 2,130 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2007
- U.S. locations
- 61
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Northport, Alabama + 58 more
- Conditions
- Hypercholesterolemia
- Interventions
- Lapaquistat acetate and stable statin therapy, Stable statin therapy
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 411 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 86
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 83 more
- Conditions
- Hypercholesterolemia
- Interventions
- Lapaquistat acetate and rosuvastatin, Rosuvastatin
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 415 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 82
- States / cities
- Birmingham, Alabama • Haleyville, Alabama • Mobile, Alabama + 79 more